https://scholars.lib.ntu.edu.tw/handle/123456789/512408
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | CHIA-JUNG LIU | en_US |
dc.contributor.author | Huang H.-L. | en_US |
dc.contributor.author | Cheng M.-H. | en_US |
dc.contributor.author | Lu P.-L. | en_US |
dc.contributor.author | CHIN-CHUNG SHU | en_US |
dc.contributor.author | JANN-YUAN WANG | en_US |
dc.contributor.author | Chong I.-W. | en_US |
dc.creator | Liu C.-J.;Huang H.-L.;Cheng M.-H.;Lu P.-L.;Shu C.-C.;Jann-Yuan Wang;Chong I.-W. | - |
dc.date.accessioned | 2020-08-13T05:24:00Z | - |
dc.date.available | 2020-08-13T05:24:00Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 0954-6111 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063662382&doi=10.1016%2fj.rmed.2019.03.015&partnerID=40&md5=2c4325ce7e33069df0a902a4dce1e0d2 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/512408 | - |
dc.description.abstract | Background: Aggressive therapy for Mycobacterium kansasii-pulmonary disease (MK-PD) is recommended because of the virulence of MK. However, some clinicians may be concerned regarding the lengthy course and numerous adverse effects. This study evaluated the natural course of MK-PD and investigated its prognostic factors. Methods: Radiographic outcome, prognostic factors, and mortality within 1 year for MK-PD were obtained from patients in 6 hospitals in Taiwan from 2010 to 2014 (derivation cohort) and validated using patients in 2015 and 2016 (validation cohort). Results: Of the 109 patients with MK-PD in the derivation cohort, radiographic progression occurred in 70 (64%), with a 1-year mortality rate of 43% and median survival of 71 days, whereas none of the 39 cases without radiographic progression died. All patients with acid-fast smear (AFS) grade ? 3 experienced radiographic progression. For the others, the independent risk factors of radiographic progression were fibroCavitary pattern, Leucocyte count >9000/μL, Old age (age >65 years), pUre MK in sputum (no other mycobacteria), and no Diabetes mellitus (the CLOUD factors). By applying these criteria to the validation cohort (n = 112), 3 (9%) of the 33 patients with MK-PD who initially had AFS grade < 3 and < 3 CLOUD risk factors experienced radiographic progression, and none of the 3 died of MK-PD. Conclusions: Because of the high risk of radiographic progression and subsequent fatal outcome, immediate anti-MK treatment is recommended. For patients with MK-PD who have sputum AFS grade <3 and < 3 CLOUD risk factors, regular follow-up may be an alternative. ? 2019 The Author(s) | en_US |
dc.publisher | W.B. Saunders Ltd | en_US |
dc.relation.ispartof | Respiratory Medicine | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | acid fast smear; age; aged; Article; atypical mycobacteriosis; clinical article; cohort analysis; female; human; leukocyte count; lung infection; male; median survival time; mortality rate; Mycobacterium kansasii; nonhuman; outcome assessment; priority journal; prognostic assessment; retrospective study; risk factor; smear; sputum analysis; Taiwan; thorax radiography; atypical mycobacteriosis; body mass; diagnostic imaging; disease exacerbation; epidemiology; leukocytosis; lung disease; microbiology; mortality; prognosis; radiography; sputum; Age Factors; Aged; Body Mass Index; Cohort Studies; Disease Progression; Female; Humans; Leukocytosis; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Prognosis; Radiography; Retrospective Studies; Risk Factors; Sputum; Taiwan | - |
dc.title | Outcome of patients with and poor prognostic factors for Mycobacterium kansasii-pulmonary disease | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.rmed.2019.03.015 | - |
dc.identifier.pmid | 31047113 | - |
dc.identifier.scopus | 2-s2.0-85063662382 | - |
dc.relation.pages | 19-26 | en_US |
dc.relation.journalvolume | 151 | en_US |
item.openairetype | journal article | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Internal Medicine-NTUHHC | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine-NTUHHC | - |
crisitem.author.orcid | 0000-0003-0311-5148 | - |
crisitem.author.orcid | 0000-0003-3406-366X | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。